## Core Concept
Neuroblastoma is a type of cancer that primarily affects children and originates from immature nerve cells, or neuroblasts, in several areas of the body. Prognostic factors for neuroblastoma include age at diagnosis, stage of the disease, histopathological features, and genetic abnormalities. Understanding these factors is crucial for determining the appropriate treatment and predicting outcomes.

## Why the Correct Answer is Right
The correct answer, **Trk A (NTRK1) expression**, is associated with a good prognosis in neuroblastoma. Trk A (also known as NTRK1) is a high-affinity nerve growth factor receptor. Expression of Trk A in neuroblastoma cells is correlated with differentiation and a favorable prognosis. This is because Trk A signaling promotes neuronal differentiation and survival, which can lead to a more benign course of the disease.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is blank and does not provide any information to evaluate.
- **Option B:** This option is also blank and cannot be assessed.
- **Option C:** Similarly, this option lacks content and cannot be considered.
- **Option D:** This option is blank as well, making it impossible to evaluate.

## Clinical Pearl / High-Yield Fact
A key clinical pearl for neuroblastoma is that **age at diagnosis and MYCN amplification status** are critical prognostic factors. Children under 18 months tend to have a better prognosis than older children. Additionally, MYCN amplification is associated with a poorer prognosis and more aggressive disease. The presence of Trk A expression, as mentioned, is a good prognostic indicator.

## Correct Answer Line
**Correct Answer: B. Trk A (NTRK1) expression.**